KYVERNA THERAPEUTICS

kyverna-therapeutics-logo

KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. Their therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

KYVERNA THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2018-01-01

Address:
Berkeley, California, United States

Country:
United States

Website Url:
http://www.kyvernatx.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
110 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

parthenon-therapeutics-logo

Parthenon Therapeutics

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

werewolf-therapeutics-logo

Werewolf Therapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.


Current Advisors List

heba-nowyhed_image

Heba Nowyhed Board Observer @ Kyverna Therapeutics
Board_observer

desmond-padhi_image

Desmond Padhi Board Observer @ Kyverna Therapeutics
Board_observer

not_available_image

Chris Liu Board Observer @ Kyverna Therapeutics
Board_observer

shaan-gandhi_image

Shaan Gandhi Board Member @ Kyverna Therapeutics
Board_member
2022-01-01

dominic-borie_image

Dominic Borie Board Member @ Kyverna Therapeutics
Board_member

mark-genovese_image

Mark Genovese Board Member @ Kyverna Therapeutics
Board_member

brian-l-kotzin_image

Brian L. Kotzin Board Member @ Kyverna Therapeutics
Board_member

daniel-spiegelman_image

Daniel Spiegelman Board Member @ Kyverna Therapeutics
Board_member

Current Employees Featured

tom-van-blarcom_image

Tom Van Blarcom
Tom Van Blarcom Senior Vice President, Head of Research @ Kyverna Therapeutics
Senior Vice President, Head of Research
2022-08-01

dominic-borie_image

Dominic Borie
Dominic Borie CEO @ Kyverna Therapeutics
CEO

jeffrey-greve_image

Jeffrey Greve
Jeffrey Greve Co-Founder and Chief Scientific Officer @ Kyverna Therapeutics
Co-Founder and Chief Scientific Officer
2018-05-01

karen-walker_image

Karen Walker
Karen Walker Chief Technical Officer @ Kyverna Therapeutics
Chief Technical Officer
2021-09-01

Founder


jeffrey-greve_image

Jeffrey Greve

Investors List

westlake-village-biopartners_image

Westlake Village BioPartners

Westlake Village BioPartners investment in Series B - Kyverna Therapeutics

hudson-bay-capital-management_image

Hudson Bay Capital Management

Hudson Bay Capital Management investment in Series B - Kyverna Therapeutics

rtw-investments-llc_image

RTW Investments LLC

RTW Investments LLC investment in Series B - Kyverna Therapeutics

vida-ventures_image

Vida Ventures

Vida Ventures investment in Series B - Kyverna Therapeutics

the-argentum-group_image

The Argentum Group

The Argentum Group investment in Series B - Kyverna Therapeutics

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Series B - Kyverna Therapeutics

camcapital_image

CAM Capital

CAM Capital investment in Series B - Kyverna Therapeutics

insight-partners_image

Insight Partners

Insight Partners investment in Series B - Kyverna Therapeutics

lyfe-capital-2_image

LYFE Capital

LYFE Capital investment in Series B - Kyverna Therapeutics

intellia-therapeutics_image

Intellia Therapeutics

Intellia Therapeutics investment in Series B - Kyverna Therapeutics

Official Site Inspections

http://www.kyvernatx.com Semrush global rank: 7.27 M Semrush visits lastest month: 548

  • Host name: 37.120.75.34.bc.googleusercontent.com
  • IP address: 34.75.120.37
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Kyverna Therapeutics" on Search Engine